(Q50962651)

English

Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial.

scientific article published on 21 February 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

0 references

Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial. (English)

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

myocardial infarction

1 reference

based on heuristic

inferred from title

13

object named as

Ingo Eitel

1 reference

Europe PubMed Central

26 March 2018

1

object named as

Holger Thiele

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

14

object named as

Steffen Desch

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

Gerhard Schuler

15

object named as

Gerhard Schuler

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

Rainer Hambrecht

3

object named as

Rainer Hambrecht

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

2

object named as

Jochen Wöhrle

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

Sebastian Kerber

11

object named as

Sebastian Kerber

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

Ralf Birkemeyer

5

object named as

Ralf Birkemeyer

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

8

object named as

Oana Brosteanu

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

7

object named as

Petra Neuhaus

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

4

object named as

Harald Rittger

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

Klaus Kleinertz

12

object named as

Klaus Kleinertz

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

author name string

Bernward Lauer

6

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

Peter Sick

9

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

Marcus Wiemer

10

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

language of work or name

0 references

publication date

21 February 2012

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

379

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

9819

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

923-931

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology:

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Myocardial no-reflow in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of glycoprotein IIb/IIIa receptor blockade on recovery of coronary flow and left ventricular function after the placement of coronary-artery stents in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracoronary eptifibatide bolus administration during percutaneous coronary revascularization for acute coronary syndromes with evaluation of platelet glycoprotein IIb/IIIa receptor occupancy and platelet function: the Intracoronary Eptifibatide (I

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intraveno

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet inhibition and GP IIb/IIIa receptor occupancy by intracoronary versus intravenous bolus administration of abciximab in patients with ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention: design and rationale of the Abciximab Intracoronary versus intravenously Drug Application in ST-Elevation Myocardial Infarction (A

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic impact of early ST-segment resolution in acute ST-elevation myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracoronary compared to intravenous Abciximab and high-dose bolus compared to standard dose in patients with ST-segment elevation myocardial infarction undergoing transradial primary percutaneous coronary intervention: a two-by-two factorial place

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention--effects on soluble CD40 ligand concentrations.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracoronary compared to intravenous bolus abciximab during primary percutaneous coronary intervention in ST-segment Elevation Myocardial Infarction (STEMI) patients reduces 30-day mortality and target vessel revascularization: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of the INFUSE-AMI study: A 2 × 2 factorial, randomized, multicenter, single-blind evaluation of intracoronary abciximab infusion and aspiration thrombectomy in patients undergoing percutaneous coronary intervention for anterior

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Abciximab in patients with acute ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention after clopidogrel loading: a randomized double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prasugrel versus clopidogrel in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Bivalirudin during primary PCI in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2961872-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(11)61872-2

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

1 reference

Europe PubMed Central

26 March 2018

http://europepmc.org/abstract/MED/22357109

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50962651&oldid=1762517494"